Fulgent Genetics, Inc. FLGT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.14M-14.6% | $83.34M-0.9% | $84.07M+2.8% | $81.8M+11.4% | $73.46M-3.6% | ||
| $49.65M-2.2% | $50.75M+4.5% | $48.56M+2.5% | $47.37M+5.0% | $45.12M+1.7% | ||
| $21.49M-34.0% | $32.58M-8.3% | $35.51M+3.1% | $34.44M+21.5% | $28.35M-11.0% | ||
| 30.2%-8.9pp | 39.1%-3.1pp | 42.2%+0.1pp | 42.1%+3.5pp | 38.6%-3.2pp | ||
| $14.18M0.0% | $14.17M+2.2% | $13.86M+2.8% | $13.48M+8.8% | $12.4M+2.3% | ||
| $12.22M+11.3% | $10.98M-5.7% | $11.64M-5.2% | $12.29M+45.1% | $8.47M-11.2% | ||
| $27.68M-33.5% | $41.65M+78.5% | $23.34M-11.6% | $26.39M+4.4% | $25.29M+3.9% | ||
| $2.03M+0.2% | $2.03M0.0% | $2.03M+1.8% | $1.99M0.0% | $1.99M-0.1% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $56.11M-18.5% | $68.82M+35.3% | $50.86M-6.1% | $54.15M+12.5% | $48.14M+0.3% | ||
| $56.11M-18.5% | $68.82M+35.3% | $50.86M-6.1% | $54.15M+12.5% | $48.14M+0.3% | ||
| -$34.62M+4.5% | -$36.24M-136% | -$15.35M+22.1% | -$19.71M+0.4% | -$19.8M-22.7% | ||
| -48.7%-5.2pp | -43.5%-25.2pp | -18.3%+5.8pp | -24.1%+2.8pp | -26.9%-5.8pp | ||
| $17K+6.3% | $16K-42.9% | $28K+64.7% | $17K+21.4% | $14K— | ||
| $8.65M+24.7% | $6.94M-11.9% | $7.87M-2.7% | $8.09M+0.9% | $8.02M-1.3% | ||
| $8.64M+24.1% | $6.96M-11.2% | $7.84M+534% | -$1.81M-122% | $8.07M-0.2% | ||
| -$25.98M+11.3% | -$29.27M-290% | -$7.51M+65.1% | -$21.52M-83.6% | -$11.72M-45.7% | ||
| -$704K+87.5% | -$5.62M-723% | -$683K+69.8% | -$2.26M-1,386% | $176K+109% | ||
| -$24.83M-6.0% | -$23.42M-254% | -$6.61M+65.1% | -$18.96M-64.4% | -$11.53M-95.8% | ||
| -34.9%-6.8pp | -28.1%-20.2pp | -7.9%+15.3pp | -23.2%-7.5pp | -15.7%-8.0pp | ||
| -$0.80-5.3% | -$0.76-262% | -$0.21+66.1% | -$0.62-67.6% | -$0.37-94.7% | ||
| -$0.80-5.3% | -$0.76-262% | -$0.21+66.1% | -$0.62-67.6% | -$0.37-94.7% | ||
| 30.9M+0.3% | 30.8M+0.1% | 30.7M+0.7% | 30.5M-0.9% | 30.8M+2.0% | ||
| 30.9M+0.3% | 30.8M+0.1% | 30.7M+0.7% | 30.5M-0.9% | 30.8M+2.0% | ||
| -$0.8-5.3% | -$0.76-262% | -$0.21+66.1% | -$0.62-67.6% | -$0.37-94.7% | ||
| -$0.8-5.3% | -$0.76-262% | -$0.21+66.1% | -$0.62-67.6% | -$0.37-94.7% | ||
| $2.03M+0.2% | $2.03M0.0% | $2.03M+1.8% | $1.99M0.0% | $1.99M-0.1% | ||
| -$1.12M-977% | -$104K+88.0% | -$864K-665% | -$113K+15.0% | -$133K+63.5% | ||
| $88K0.0% | $88K0.0% | $88K+1.1% | $87K-36.0% | $136K0.0% | ||
| $9K— | —— | $1K— | —— | $2K+102% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$408K-144% | $924K+1,006% | -$102K-126% | $386K+159% | -$658K— | ||
| -$16.43M-207% | $15.38M— | —— | $8.26M+82.5% | $4.52M-66.0% | ||
| -$2.12M-117% | $12.33M+1,189% | -$1.13M-122% | $5.2M+170% | -$7.49M— | ||
| -$2.79M-53.1% | -$1.82M-233% | $1.37M— | —— | -$804K-3.7% | ||
| -$44.83M-8,296% | -$534K-20.0% | -$445K+83.1% | -$2.64M+76.4% | -$11.17M-3,317% | ||
| $10.94M-1.9% | $11.15M-41.6% | $19.08M-64.3% | $53.4M+92.6% | $27.73M+201% | ||
| $7.1M+109% | -$78.14M— | —— | -$30.17M-581% | -$4.43M-118% | ||
| -$1K— | —— | -$1K+91.7% | -$12K+42.9% | -$21K-200% | ||
| $10K-77.3% | $44K+980% | -$5K-111% | $46K-32.4% | $68K+871% | ||
| $40.08M— | —— | —— | $2.21M-74.6% | $8.68M— | ||
| $4.2M+840% | $447K+25.2% | $357K+3.5% | $345K-81.7% | $1.89M+680% | ||
| $55.57M— | —— | —— | —— | $0— | ||
| $5.2M+4.5% | $4.98M-17.7% | $6.05M-11.4% | $6.83M+44.7% | $4.72M+24.9% | ||
| $8K— | —— | $3K— | —— | $2K— | ||
| $9K— | —— | —— | —— | $0-100% | ||
| $1.19M-35.9% | $1.85M+64.4% | $1.13M-56.5% | $2.59M+24.9% | $2.08M— | ||
| $71.14M-14.6% | $83.34M-0.9% | $84.07M+2.8% | $81.8M+11.4% | $73.46M-3.6% | ||
| $9.89M+6.6% | $9.28M-4.5% | $9.72M-3.2% | $10.04M-4.8% | $10.55M+1.4% | ||
| -$34.62M+4.5% | -$36.24M-136% | -$15.35M+22.1% | -$19.71M+0.4% | -$19.8M-22.7% | ||
| -$28.62M+5.0% | -$30.13M-224% | -$9.31M+31.8% | -$13.66M+1.6% | -$13.88M-39.6% | ||
| -$28.62M+5.0% | -$30.13M-224% | -$9.31M+31.8% | -$13.66M+1.6% | -$13.88M-39.6% | ||
| -40.2%-4.1pp | -36.2%-25.1pp | -11.1%+5.6pp | -16.7%+2.2pp | -18.9%-5.8pp | ||
| -$34.62M+4.5% | -$36.24M-136% | -$15.35M+22.1% | -$19.71M+0.4% | -$19.8M-22.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Fulgent Genetics, Inc.'s revenue?
- Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
- Is Fulgent Genetics, Inc. profitable?
- Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
- What are Fulgent Genetics, Inc.'s profit margins?
- Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
- What is Fulgent Genetics, Inc.'s earnings per share?
- Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
- Where does Fulgent Genetics, Inc.'s income statement data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
